Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder
2024-515475-35-00Phase 2Completed
- Sponsor
- Universitätsmedizin Göttingen
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in binge eating disorder (BED) comparing Hydrocortisone + food exposure therapy with Placebo + food exposure therapy (2 arms). Started Jul 2024; status: completed.
02
Drugs
hydrocortisone
03
Conditions
binge eating disorder (BED)
Beyond the preview
Go deeper on 2024-515475-35-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515475-35-00.